Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.

Source:http://linkedlifedata.com/resource/pubmed/id/18001228

Download in:

View as

General Info

PMID
18001228